Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.54 SEK | -0.19% | -10.37% | +212.76% |
May. 07 | Transcript : Ascelia Pharma AB - Special Call | |
May. 02 | Ascelia Pharma AB Successfully Meets Primary Endpoint with Strong Headline Results in Orvigance Phase 3 Study | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+212.76% | 32.81M | |
+23.37% | 47.02B | |
+49.84% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- ACE Stock
- News Ascelia Pharma AB
- Transcript : Ascelia Pharma AB, 2022 Earnings Call, Feb 10, 2023